Zhifei Longcom Passes EU QP Audit, An Acceleration in Zhifei’s International Strategic Layout2022-11-09

On November 8, 2022, the Recombinant COVID-19 Vaccine (CHO Cell) and the Recombinant COVID-19 Omicron-Delta Variant Vaccine (CHO Cell) of An...

Zhifei’s Second-generation Recombinant COVID-19 Vaccine Starts International Clinical Trial2022-11-09

Source: Xinhua News Agency The launch ceremony of the international clinical trial of the Recombinant COVID-19 Omicron-Delta Variant Vaccin...

WHO Announces Updates to its Guidelines on Tests for the Diagnosis of TB Infection2022-10-08

On September 30, World Health Organization (WHO) published its updated consolidated guidelines on tuberculosis (TB) and the use of tests fo...

WHO announces updates on new TB antigen-based skin tests for the diagnosis of TB infection2022-09-30

From WHO Official WebsiteA Guideline Development Group was convened by World Health Organization (WHO) from 31 January to 3 February 2022 t...

Zhifei Actively Participates in China-Uzbekistan Vaccine Cooperation2022-09-18

Chinese President Xi Jinping paid a state visit to Uzbekistan during 14th-15th Sep. In time of the visit, the two heads of state said that b...